Versatility of different pharmaceutical formulations of hydromorphone in the management of severe cancer pain and pain in palliative care

Author： Clemens Katri E   Likar Rudolf  

Publisher： Future Medicine

ISSN： 1758-1869

Source： Pain Management, Vol.3, Iss.5, 2013-09, pp. : 369-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical application of extended-release hydromorphone for pain management

By Grider Jay S  

Therapy, Vol. 6, Iss. 5, 2009-09 ,pp. : 653-656

Future Medicine

Access to resources Recommend Favorite

Availability and approval of cannabis‐based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 22, Iss. 3, 2018-03 ,pp. : 440-454

John Wiley & Sons Inc

Access to resources Recommend Favorite

Corticosteroids as co‐analgesics with opioids for cancer pain: a survey of Australian and New Zealand palliative care clinicians

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 12, 2015-12 ,pp. : 1306-1310

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Use of High Dosages of Transdermal Buprenorphine for Pain Management in Palliative Cancer Patients: A Case Study

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-03 ,pp. : 169-173

Karger

Access to resources Recommend Favorite

Progress of Cancer Pain Management in Korea

By  

Oncology, Vol. 74, Iss. 1, 2008-08 ,pp. : 4-6

Karger

Access to resources Recommend Favorite